Predictive Oncology Inc. (POAI)

USD 0.98

(-11.71%)

Net Debt Summary of Predictive Oncology Inc.

  • Predictive Oncology Inc.'s latest annual net debt in 2023 was -5.87 Million USD , up 73.18% from previous year.
  • Predictive Oncology Inc.'s latest quarterly net debt in 2024 Q1 was -2.59 Million USD , up 55.86% from previous quarter.
  • Predictive Oncology Inc. reported annual net debt of -21.89 Million USD in 2022, up 19.88% from previous year.
  • Predictive Oncology Inc. reported annual net debt of -27.32 Million USD in 2021, down -625.83% from previous year.
  • Predictive Oncology Inc. reported quarterly net debt of -2.63 Million USD for 2024 Q2, down -1.56% from previous quarter.
  • Predictive Oncology Inc. reported quarterly net debt of -5.87 Million USD for 2023 FY, up 73.18% from previous quarter.

Annual Net Debt Chart of Predictive Oncology Inc. (2023 - 2008)

Historical Annual Net Debt of Predictive Oncology Inc. (2023 - 2008)

Year Net Debt Net Debt Growth
2023 -5.87 Million USD 73.18%
2022 -21.89 Million USD 19.88%
2021 -27.32 Million USD -625.83%
2020 5.19 Million USD -3.32%
2019 5.37 Million USD 264.94%
2018 1.47 Million USD 292.22%
2017 -766.18 Thousand USD 56.57%
2016 -1.76 Million USD 63.67%
2015 -4.85 Million USD -627.26%
2014 921.04 Thousand USD 417.3%
2013 178.04 Thousand USD -84.62%
2012 1.15 Million USD -25.94%
2011 1.56 Million USD 46.92%
2010 1.06 Million USD 514.5%
2009 173.09 Thousand USD 203.15%
2008 -167.81 Thousand USD 0.0%

Peer Net Debt Comparison of Predictive Oncology Inc.

Name Net Debt Net Debt Difference
Akoya Biosciences, Inc. 2.58 Million USD 327.503%
AngioDynamics, Inc. -70.14 Million USD 91.629%
AtriCure, Inc. -9.81 Million USD 40.181%
Avinger, Inc. 10.12 Million USD 158.022%
Azenta, Inc. -618.47 Million USD 99.051%
BioLife Solutions, Inc. 7.25 Million USD 180.957%
The Cooper Companies, Inc. 2.44 Billion USD 100.24%
Daxor Corporation 755.65 Thousand USD 877.05%
Ekso Bionics Holdings, Inc. -1.47 Million USD -299.445%
Femasys Inc. -15.01 Million USD 60.894%
GlucoTrack, Inc. -4.29 Million USD -36.682%
Harvard Bioscience, Inc. 38.49 Million USD 115.256%
Hologic, Inc. 374.4 Million USD 101.568%
ICU Medical, Inc. 1.45 Billion USD 100.405%
Intuitive Surgical, Inc. -2.66 Billion USD 99.779%
KORU Medical Systems, Inc. -7.03 Million USD 16.559%
LeMaitre Vascular, Inc. -5.17 Million USD -13.488%
Innovative Eyewear, Inc. -4.28 Million USD -36.954%
Innovative Eyewear, Inc. -4.28 Million USD -36.954%
Masimo Corporation 804 Million USD 100.73%
Microbot Medical Inc. -2.28 Million USD -156.861%
Meihua International Medical Technologies Co., Ltd. -9.59 Million USD 38.808%
Merit Medical Systems, Inc. 302.22 Million USD 101.943%
Nephros, Inc. -2.47 Million USD -137.63%
NovoCure Limited 355.42 Million USD 101.652%
NEXGEL, Inc. 98 Thousand USD 6091.68%
NEXGEL, Inc. 98 Thousand USD 6091.68%
Singular Genomics Systems, Inc. 59.05 Million USD 109.943%
OraSure Technologies, Inc. -276.9 Million USD 97.879%
Pro-Dex, Inc. 10.91 Million USD 153.791%
Pulse Biosciences, Inc. -35.22 Million USD 83.329%
Precision Optics Corporation, Inc. 3.02 Million USD 293.843%
QuidelOrtho Corporation 2.49 Billion USD 100.235%
Repligen Corporation -39.51 Million USD 85.142%
Sanara MedTech Inc. 6.64 Million USD 188.366%
STAAR Surgical Company -147.2 Million USD 96.011%
Sharps Technology, Inc. -3.01 Million USD -94.89%
Utah Medical Products, Inc. -92.52 Million USD 93.654%
DENTSPLY SIRONA Inc. 1.96 Billion USD 100.299%
Jin Medical International Ltd. -2.81 Million USD -108.48%